Sanger Buys an Illumina Genotyping System
The Wellcome Trust Sanger Institute has bought one of Illumina’s SNP-genotyping labs. The British center will use the gargantuan system for large genotyping projects, including the International HapMap project, Illumina said Feb. 18.
The Wellcome Trust Sanger Institute is the second node of the International HapMap project to purchase an Illumina genotyping system. Genome Quebec, which is conducting genotyping for Genome Canada’s portion of the HapMap, purchased a system Jan. 9.